CKIP-1 is an intrinsic negative regulator of T-cell activation through an interaction with CARMA1

Area of Science:

• Immunology
• Molecular Biology
• Cell Signaling

Background:

• Nuclear factor-kappa B (NF-κB) is crucial for lymphocyte activation and immune responses.
• T cell receptor (TCR) stimulation initiates a signaling cascade involving PKCθ and the CARMA1-Bcl10-MALT1 (CBM) complex, leading to NF-κB activation.
• Mechanisms of negative regulation for TCR-mediated NF-κB activation remain incompletely understood.

Purpose of the Study:

• To identify negative regulators of TCR-mediated NF-κB activation.
• To elucidate the role of casein kinase-2 interacting protein-1 (CKIP-1) in regulating T cell signaling.

Main Methods:

• Cell-based screening using mutagenesis and complementation cloning.
• Co-immunoprecipitation assays to detect protein interactions.
• Analysis of NF-κB activity following various stimulation methods (PMA, TNFα, CD3/CD28 costimulation).

Main Results:

• CKIP-1 was identified as a suppressor of PKCθ-CBM-NF-κB signaling.
• CKIP-1 directly interacts with CARMA1, competing with PKCθ binding.
• The PH domain of CKIP-1 is essential for CARMA1 interaction and inhibitory function.
• CKIP-1 inhibits NF-κB activation induced by PMA or activated PKCθ, but not TNFα or CD3/CD28 costimulation.
• CD3/CD28 costimulation leads to CKIP-1 dissociation from lipid rafts, abrogating its inhibitory effect.

Conclusions:

• CKIP-1 negatively regulates TCR-mediated NF-κB activation by inhibiting the PKCθ-CBM complex.
• CKIP-1 plays a role in maintaining T cell quiescence and preventing aberrant activation.
• CKIP-1's interaction with CARMA1 is critical for its suppressive function in T cell signaling.